ABIN-1 is a key regulator, and its deficiency may facilitate necroptosis-based antitumor therapy by increasing the sensitivity of CRC cells to necroptosis (Cai et al., 2021). The gene discussed is TNIP1; the disease is colorectal carcinoma.